JP2006096734A5 - - Google Patents

Download PDF

Info

Publication number
JP2006096734A5
JP2006096734A5 JP2004315009A JP2004315009A JP2006096734A5 JP 2006096734 A5 JP2006096734 A5 JP 2006096734A5 JP 2004315009 A JP2004315009 A JP 2004315009A JP 2004315009 A JP2004315009 A JP 2004315009A JP 2006096734 A5 JP2006096734 A5 JP 2006096734A5
Authority
JP
Japan
Prior art keywords
hydrogen
alkyl
formula
alkoxy
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004315009A
Other languages
English (en)
Japanese (ja)
Other versions
JP4976649B2 (ja
JP2006096734A (ja
Filing date
Publication date
Application filed filed Critical
Priority to AU2005201855A priority Critical patent/AU2005201855B2/en
Priority to CA 2506238 priority patent/CA2506238C/en
Priority to US11/230,505 priority patent/US8080675B2/en
Priority to ES11180383.9T priority patent/ES2586847T3/es
Priority to MX2007003215A priority patent/MX2007003215A/es
Priority to NZ553835A priority patent/NZ553835A/en
Priority to ES05787045T priority patent/ES2431045T3/es
Priority to HK08101549.6A priority patent/HK1112617B/xx
Priority to CN2005800380156A priority patent/CN101094844B/zh
Priority to PCT/AU2005/001436 priority patent/WO2006032086A1/en
Priority to EP05787045.3A priority patent/EP1809618B1/en
Priority to EP11180383.9A priority patent/EP2436680B1/en
Publication of JP2006096734A publication Critical patent/JP2006096734A/ja
Priority to IL182042A priority patent/IL182042A/en
Priority to NO20071578A priority patent/NO20071578L/no
Publication of JP2006096734A5 publication Critical patent/JP2006096734A5/ja
Priority to US13/231,794 priority patent/US8163795B2/en
Priority to US13/415,697 priority patent/US8461361B2/en
Application granted granted Critical
Publication of JP4976649B2 publication Critical patent/JP4976649B2/ja
Priority to US13/891,975 priority patent/US8957109B2/en
Priority to US14/589,941 priority patent/US9198895B2/en
Priority to US14/922,472 priority patent/US20160136129A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004315009A 2004-09-21 2004-10-29 化合物 Expired - Fee Related JP4976649B2 (ja)

Priority Applications (19)

Application Number Priority Date Filing Date Title
CA 2506238 CA2506238C (en) 2004-09-21 2005-05-03 Chroman derived compounds & formulations thereof for use in therapy
AU2005201855A AU2005201855B2 (en) 2004-09-21 2005-05-03 Chroman derived compounds and formulations thereof for use in therapy
ES11180383.9T ES2586847T3 (es) 2004-09-21 2005-09-21 Derivados de cromano, medicamentos y uso terapéutico
MX2007003215A MX2007003215A (es) 2004-09-21 2005-09-21 Cromaderivados, medicamentos y su uso en terapias.
NZ553835A NZ553835A (en) 2004-09-21 2005-09-21 7-hydroxy-3,4-diphenyl-chroman derivatives
ES05787045T ES2431045T3 (es) 2004-09-21 2005-09-21 Derivados de cromano, medicamentos y uso terapéutico
HK08101549.6A HK1112617B (en) 2004-09-21 2005-09-21 Chroman derivatives, medicaments and use in therapy
CN2005800380156A CN101094844B (zh) 2004-09-21 2005-09-21 苯并二氢吡喃衍生物，药物及其在治疗中的应用
PCT/AU2005/001436 WO2006032086A1 (en) 2004-09-21 2005-09-21 Chroman derivatives, medicaments and use in therapy
EP05787045.3A EP1809618B1 (en) 2004-09-21 2005-09-21 Chroman derivatives, medicaments and use in therapy
US11/230,505 US8080675B2 (en) 2004-09-21 2005-09-21 Chroman derivatives, medicaments and use in therapy
EP11180383.9A EP2436680B1 (en) 2004-09-21 2005-09-21 Chroman derivatives, medicaments and use in therapy
IL182042A IL182042A (en) 2004-09-21 2007-03-20 Chroman derivatives, medicaments and use in therapy
NO20071578A NO20071578L (no) 2004-09-21 2007-03-26 Kromanderivater, legemidler og anvendelse i terapi
US13/231,794 US8163795B2 (en) 2004-09-21 2011-09-13 Chroman derivatives, medicaments and use in therapy
US13/415,697 US8461361B2 (en) 2004-09-21 2012-03-08 Chroman derivatives, medicaments and use in therapy
US13/891,975 US8957109B2 (en) 2004-09-21 2013-05-10 Chroman derivatives, medicaments and use in therapy
US14/589,941 US9198895B2 (en) 2004-09-21 2015-01-05 Chroman derivatives, medicaments and use in therapy
US14/922,472 US20160136129A1 (en) 2004-09-21 2015-10-26 Chroman derivatives, medicaments and use in therapy

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61129904P 2004-09-21 2004-09-21
US60/611299 2004-09-21

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012040002A Division JP2012144537A (ja) 2004-09-21 2012-02-27 化合物

Publications (3)

Publication Number Publication Date
JP2006096734A JP2006096734A (ja) 2006-04-13
JP2006096734A5 true JP2006096734A5 (enExample) 2008-02-28
JP4976649B2 JP4976649B2 (ja) 2012-07-18

Family

ID=34956540

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2004315009A Expired - Fee Related JP4976649B2 (ja) 2004-09-21 2004-10-29 化合物
JP2012040002A Pending JP2012144537A (ja) 2004-09-21 2012-02-27 化合物
JP2014104217A Expired - Fee Related JP5816868B2 (ja) 2004-09-21 2014-05-20 化合物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2012040002A Pending JP2012144537A (ja) 2004-09-21 2012-02-27 化合物
JP2014104217A Expired - Fee Related JP5816868B2 (ja) 2004-09-21 2014-05-20 化合物

Country Status (2)

Country Link
JP (3) JP4976649B2 (enExample)
CN (1) CN101094844B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4976649B2 (ja) * 2004-09-21 2012-07-18 マーシャル エドワーズ，インク． 化合物
AU2005287865B2 (en) 2004-09-21 2012-02-16 Marshall Edwards, Inc. Substituted chroman derivatives, medicaments and use in therapy
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
WO2012061413A2 (en) 2010-11-01 2012-05-10 Marshall Edwards, Inc. Isoflavonoid compositions and methods for the treatment of cancer
CN103224481A (zh) * 2013-05-20 2013-07-31 黑龙江大学 一种去氢雌马酚的制备方法
BR112016018099B8 (pt) * 2014-02-07 2023-01-17 Novogen ltd Compostos funcionalizados de benzopiranos e uso dos mesmos
JP6218680B2 (ja) * 2014-06-11 2017-10-25 三菱電機株式会社 ネットワーク解析支援装置、ネットワーク解析支援方法、および、プログラム
AU2016215515B2 (en) 2015-02-02 2020-04-30 Mei Pharma, Inc. Combination therapies
CN108409701B (zh) * 2017-02-10 2020-09-25 山东康迈祺生物科技有限公司 一种二氢大豆苷元的制备方法
CN112920173A (zh) * 2021-01-25 2021-06-08 江苏师范大学 一种手性苯并二氢吡喃化合物及其合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5883118A (en) * 1996-01-11 1999-03-16 Nova Nordisk A/S Prostatic carcinoma
ZA979643B (en) * 1996-10-28 1998-04-28 Novo Nordisk As Heterocyclic compounds, compositions and uses.
ZA979650B (en) * 1996-10-28 1998-04-28 Novo Nordisk As Heterocyclic compounds, compositions and uses.
KR20000001793A (ko) * 1998-06-13 2000-01-15 이경하 신규한 벤조피란 또는 티오벤조피란 유도체
ATE286894T1 (de) * 2001-01-24 2005-01-15 Chiesi Farma Spa 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
JP4976649B2 (ja) * 2004-09-21 2012-07-18 マーシャル エドワーズ，インク． 化合物

Similar Documents

Publication Publication Date Title
JP2012144537A5 (enExample)
JP2010530881A5 (enExample)
JP2002513793A5 (enExample)
JP2005536503A5 (enExample)
EP2308828A3 (en) CaSR antagonist
JP2006096734A5 (enExample)
JP2003503449A5 (enExample)
JP2004529172A5 (enExample)
JP2008502694A (ja) ボリン酸錯体の抗ウイルス使用
FI91156B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi
JP2005516898A5 (enExample)
US4340760A (en) Monophenylamine derivatives
JP2004538278A5 (enExample)
CA2452920A1 (en) Benzo [g] quinoline derivatives for treating glaucoma and myopia
US4658063A (en) Isoprenylamine derivatives
CN104250247B (zh) 新型槐定碱类衍生物槐定酸、槐定醇、槐定酯、槐定醚及其制备方法和用途
US4568765A (en) Isoprenylamine derivatives
US4324916A (en) Decaprenylamine derivatives
US4755601A (en) Nonyl prenyl-N heterocyclics
US4322555A (en) Nonaprenylamine derivatives
JPWO2005004868A1 (ja) 抗コロナウイルス剤
JP2520244B2 (ja) 弗素化ジアミノアルキン誘導体
JPH0128738B2 (enExample)
US4380668A (en) Decaprenylamine derivatives
US4431811A (en) Decaprenylamine derivatives